{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T11:02:07Z","timestamp":1794049327483,"version":"4.8.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Natural National Science Foundation of China","doi-asserted-by":"crossref","award":["81770846"],"award-info":[{"award-number":["81770846"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"Natural National Science Foundation of China","doi-asserted-by":"crossref","award":["81642006"],"award-info":[{"award-number":["81642006"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"US Hirshberg Foundation for Pancreatic Cancer Research","award":["AH201901083"],"award-info":[{"award-number":["AH201901083"]}]},{"name":"Kante Seeds Foundation for Cancer Research","award":["KD2021030001"],"award-info":[{"award-number":["KD2021030001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s10620-024-08338-4","type":"journal-article","created":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T18:15:05Z","timestamp":1709835305000},"page":"1263-1273","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Development of a Serum-Based MicroRNA Signature for Early Detection of Pancreatic Cancer: A Multicenter Cohort Study"],"prefix":"10.1007","volume":"69","author":[{"given":"Jing","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianzhou","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongtu","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vay Liang","family":"Go","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yefu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minwei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongwei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yantao","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyuan","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junchao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary Guishan","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,7]]},"reference":[{"key":"8338_CR1","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","volume":"74","author":"L Rahib","year":"2014","unstructured":"Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74:2913\u20132921.","journal-title":"Cancer Res."},{"key":"8338_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71:7\u201333.","journal-title":"CA Cancer J Clin."},{"key":"8338_CR3","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1001\/jama.2021.13027","volume":"326","author":"W Park","year":"2021","unstructured":"Park W, Chawla A, O\u2019Reilly EM. Pancreatic cancer: a review. JAMA. 2021;326:851\u2013862.","journal-title":"JAMA."},{"key":"8338_CR4","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1053\/j.gastro.2019.01.259","volume":"156","author":"AD Singhi","year":"2019","unstructured":"Singhi AD, Koay EJ, Chari ST, Maitra A. Early detection of pancreatic cancer: opportunities and challenges. Gastroenterology. 2019;156:2024\u20132040.","journal-title":"Gastroenterology."},{"key":"8338_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-018175","volume":"7","author":"L Ge","year":"2017","unstructured":"Ge L, Pan B, Song F et al. Comparing the diagnostic accuracy of five common tumour biomarkers and CA19-9 for pancreatic cancer: a protocol for a network meta-analysis of diagnostic test accuracy. BMJ Open. 2017;7:e018175.","journal-title":"BMJ Open."},{"key":"8338_CR6","doi-asserted-by":"publisher","first-page":"742","DOI":"10.3892\/ol.2020.11633","volume":"20","author":"H Luo","year":"2020","unstructured":"Luo H, Shen K, Li B, Li R, Wang Z, Xie Z. Clinical significance and diagnostic value of serum NSE, CEA, CA19-9, CA125 and CA242 levels in colorectal cancer. Oncol Lett. 2020;20:742\u2013750.","journal-title":"Oncol Lett."},{"key":"8338_CR7","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1002\/cac2.12204","volume":"41","author":"J Yang","year":"2021","unstructured":"Yang J, Xu R, Wang C, Qiu J, Ren B, You L. Early screening and diagnosis strategies of pancreatic cancer: a comprehensive review. Cancer Commun (Lond). 2021;41:1257\u20131274.","journal-title":"Cancer Commun (Lond)."},{"key":"8338_CR8","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1186\/s12935-021-02149-7","volume":"21","author":"M Moghbeli","year":"2021","unstructured":"Moghbeli M, Zangouei AS, Nasrpour Navaii Z, Taghehchian N. Molecular mechanisms of the microRNA-132 during tumor progressions. Cancer Cell Int. 2021;21:439.","journal-title":"Cancer Cell Int."},{"key":"8338_CR9","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.pbiomolbio.2017.09.019","volume":"148","author":"H Zhang","year":"2019","unstructured":"Zhang H, Liu A, Feng X et al. MiR-132 promotes the proliferation, invasion and migration of human pancreatic carcinoma by inhibition of the tumor suppressor gene PTEN. Prog Biophys Mol Biol. 2019;148:65\u201372.","journal-title":"Prog Biophys Mol Biol."},{"key":"8338_CR10","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/s13577-016-0137-7","volume":"29","author":"K Tsukasa","year":"2016","unstructured":"Tsukasa K, Ding Q, Miyazaki Y, Matsubara S, Natsugoe S, Takao S. miR-30 family promotes migratory and invasive abilities in CD133(+) pancreatic cancer stem-like cells. Hum Cell. 2016;29:130\u2013137.","journal-title":"Hum Cell."},{"key":"8338_CR11","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.7150\/jca.25006","volume":"9","author":"Y Xiong","year":"2018","unstructured":"Xiong Y, Wang Y, Wang L et al. MicroRNA-30b targets Snail to impede epithelial-mesenchymal transition in pancreatic cancer stem cells. J Cancer. 2018;9:2147\u20132159.","journal-title":"J Cancer."},{"key":"8338_CR12","doi-asserted-by":"publisher","first-page":"43831","DOI":"10.18632\/oncotarget.6257","volume":"6","author":"R Liu","year":"2015","unstructured":"Liu R, Zhang H, Wang X et al. The miR-24-Bim pathway promotes tumor growth and angiogenesis in pancreatic carcinoma. Oncotarget. 2015;6:43831\u201343842.","journal-title":"Oncotarget."},{"key":"8338_CR13","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.cgh.2018.01.049","volume":"16","author":"SS Mukewar","year":"2018","unstructured":"Mukewar SS, Sharma A, Phillip N et al. Risk of pancreatic cancer in patients with pancreatic cysts and family history of pancreatic cancer. Clin Gastroenterol Hepatol. 2018;16:1123\u20131130.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"8338_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2019.188318","volume":"1873","author":"J Carmicheal","year":"2020","unstructured":"Carmicheal J, Patel A, Dalal V et al. Elevating pancreatic cystic lesion stratification: Current and future pancreatic cancer biomarker(s). Biochim Biophys Acta Rev CANCER. 2020;1873:188318.","journal-title":"Biochim Biophys Acta Rev CANCER."},{"key":"8338_CR15","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1001\/jama.2013.284664","volume":"311","author":"NA Schultz","year":"2014","unstructured":"Schultz NA, Dehlendorff C, Jensen BV et al. MicroRNA biomarkers in whole blood for detection of pancreatic cancer. JAMA. 2014;311:392\u2013404.","journal-title":"JAMA."},{"key":"8338_CR16","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1053\/j.gastro.2022.06.090","volume":"163","author":"K Nakamura","year":"2022","unstructured":"Nakamura K, Zhu Z, Roy S et al. An exosome-based transcriptomic signature for noninvasive, early detection of patients with pancreatic ductal adenocarcinoma: a multicenter cohort study. Gastroenterology. 2022;163:1252\u20131266.","journal-title":"Gastroenterology."},{"key":"8338_CR17","doi-asserted-by":"publisher","first-page":"8040419","DOI":"10.1155\/2022\/8040419","volume":"2022","author":"A Seyed Salehi","year":"2022","unstructured":"Seyed Salehi A, Parsa-Nikoo N, Roshan-Farzad F et al. MicroRNA-125a-3p, -4530, and -92a as a Potential Circulating MicroRNA Panel for Noninvasive Pancreatic Cancer Diagnosis. Dis Markers. 2022;2022:8040419.","journal-title":"Dis Markers."},{"key":"8338_CR18","doi-asserted-by":"publisher","first-page":"3600","DOI":"10.1158\/1078-0432.CCR-12-3092","volume":"19","author":"A Li","year":"2013","unstructured":"Li A, Jun Y, Kim H et al. MicroRNA array analysis finds elevated serum miR-1290 accurately distinguishes patients with low-stage pancreatic cancer from healthy and disease controls. Clin Cancer Res. 2013;19:3600\u20133610.","journal-title":"Clin Cancer Res."},{"key":"8338_CR19","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13048-018-0458-0","volume":"11","author":"M Kobayashi","year":"2018","unstructured":"Kobayashi M, Sawada K, Nakamura K et al. Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types. J Ovarian Res. 2018;11:81.","journal-title":"J Ovarian Res."},{"key":"8338_CR20","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/S2468-1253(19)30347-4","volume":"4","author":"GBD 2017 Pancreatic Cancer Collaborators","year":"2019","unstructured":"GBD 2017 Pancreatic Cancer Collaborators. The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2019;4:934\u2013947.","journal-title":"Lancet Gastroenterol Hepatol."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-024-08338-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-024-08338-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-024-08338-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T12:29:23Z","timestamp":1713443363000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-024-08338-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,7]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["8338"],"URL":"https:\/\/doi.org\/10.1007\/s10620-024-08338-4","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,7]]},"assertion":[{"value":"29 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki, and approved by the Institutional Review Board of the University of Nebraska Medical Center and Creighton University Medical Center (IRB#08-15183; IRB#10-15627) and the Ethical Committees of Dalian University of Technology.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Patient consent was waived due to all specimens were from participating patients who cannot be identified.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}